22 research outputs found

    Plasma Procalcitonin Concentration in Healthy Horses and Horses Affected by Systemic Inflammatory Response Syndrome

    Get PDF
    The diseases most frequent associated with in adult horses are those involving the gastrointestinal tract. An early diagnosis should be the goal in the management of horses with . The objective of this study was to evaluate the plasma procalcitonin () concentration in healthy and horses to assess differences between the two groups. Seventy-eight horses (30 healthy and 48 ). Prospective in vivo multicentric study. Horses were classified as if at least 2 of the following criteria were met: abnormal leukocyte count or distribution, hyperthermia or hypothermia, tachycardia, tachypnea. Healthy horses showed no clinical or laboratory signs of . Plasma concentrations were measured with a commercial assay for equine species. Results were expressed as mean±standard deviation. T-test for unpaired data was performed between healthy and group. group was divided in 4 subgroups and t -test was performed between healthy versus each subgroup. concentrations in healthy and horses were 18.28 ± 20.32 and 197.0 ± 117.0 pg/, respectively. T-test showed statistical differences between healthy versus group and between healthy versus all subgroups. Results showed an increase in concentration in horses as previously reported in humans and dogs. could be used as a single assay in equine practice for detection of

    Plasma Procalcitonin Concentration in Healthy Horses and Horses Affected by Systemic Inflammatory Response Syndrome

    No full text
    The diseases most frequent associated with in adult horses are those involving the gastrointestinal tract. An early diagnosis should be the goal in the management of horses with . The objective of this study was to evaluate the plasma procalcitonin () concentration in healthy and horses to assess differences between the two groups. Seventy-eight horses (30 healthy and 48 ). Prospective in vivo multicentric study. Horses were classified as if at least 2 of the following criteria were met: abnormal leukocyte count or distribution, hyperthermia or hypothermia, tachycardia, tachypnea. Healthy horses showed no clinical or laboratory signs of . Plasma concentrations were measured with a commercial assay for equine species. Results were expressed as mean±standard deviation. T-test for unpaired data was performed between healthy and group. group was divided in 4 subgroups and t -test was performed between healthy versus each subgroup. concentrations in healthy and horses were 18.28 ± 20.32 and 197.0 ± 117.0 pg/, respectively. T-test showed statistical differences between healthy versus group and between healthy versus all subgroups. Results showed an increase in concentration in horses as previously reported in humans and dogs. could be used as a single assay in equine practice for detection of
    corecore